On GoodRx’s website, users can determine which Sanofi savings program best fits their insurance status and apply for discounts. GoodRx estimated the move could save Americans up to $260 million on first-fill costs in 2021.
“Insulin costs can easily overwhelm people living with diabetes. We are proud to partner with Sanofi to make insulins and other prescriptions more affordable for all Americans, regardless of their income status,” Doug Hirsch, co-CEO and co-founder of GoodRx, said in a news release.
More articles on pharmacy:
US to share entire AstraZeneca COVID-19 vaccine supply with other nations
Cardinal launches pharmacy platform to improve medication adherence
New HHS guidelines allow nearly all healthcare providers to prescribe buprenorphine
